Literature DB >> 9209942

Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease.

R Narang1, D Ridout, C Nonis, J S Kooner.   

Abstract

Though calcium plays an important role in a number of biologic processes related to the pathogenesis of atherosclerosis, the relationship of serum calcium and phosphorus levels with the angiographic severity of coronary artery disease (CAD) is not known. We retrospectively studied 376 stable patients (age range 31-86 years, mean 59.2 +/- 10.5 years; 68% males) undergoing routine coronary angiography and related the angiographic severity of CAD with the serum levels of total and corrected calcium, phosphorus, albumin, total protein and bicarbonate. The primary variable studied was the number of vessels with haemodynamically significant disease. On univariate analysis, total serum calcium and serum albumin levels had a negative association with the number of vessels diseased (P = 0.046 and 0.057, respectively). Multiple regression analysis using age, sex, smoking, diabetes, hypertension, hyperlipidaemia, ethnicity and family history, in addition to serum calcium, phosphorus and albumin levels as the predictor variables, showed that serum albumin has an independent negative and serum phosphorus has an independent positive association with the angiographic severity of CAD (P = 0.04 and 0.003, respectively; n = 294). Serum phosphorus level also showed highly significant positive associations with the presence of total or subtotal occlusion and with most severe stenosis observed on angiography. A moderate change in the serum level of albumin or phosphorus confers a risk similar to that associated with smoking, as estimated by the odds ratios.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209942     DOI: 10.1016/s0167-5273(97)02971-9

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Authors:  Sharon M Moe; Miriam P Zidehsarai; Mary A Chambers; Lisa A Jackman; J Scott Radcliffe; Laurie L Trevino; Susan E Donahue; John R Asplin
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 8.237

2.  Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.

Authors:  Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A Hanlon; Andrew G Bostom
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

Review 3.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

Review 4.  Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Authors:  R F Gillum
Journal:  J Natl Med Assoc       Date:  2000-01       Impact factor: 1.798

Review 5.  Vascular calcification: When should we interfere in chronic kidney disease patients and how?

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-09-06

6.  Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC.

Authors:  Yiyi Zhang; Wendy S Post; Darshan Dalal; Sandeep Bansal; Elena Blasco-Colmenares; Suzanne Jan De Beur; Alvaro Alonso; Elsayed Z Soliman; Eric A Whitsel; Ramón Brugada; Gordon F Tomaselli; Eliseo Guallar
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

7.  Association of circulating calciprotein particle levels with skeletal muscle mass and strength in middle-aged and older adults.

Authors:  Masaki Yoshioka; Keisei Kosaki; Masahiro Matsui; Naoya Okabe; Chie Saito; Kunihiro Yamagata; Makoto Kuro-O; Seiji Maeda
Journal:  Hypertens Res       Date:  2022-03-03       Impact factor: 3.872

Review 8.  Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.

Authors:  Víctor Lorenzo Sellares; Armando Torres Ramírez
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Cardiovascular effects of sevelamer in stage 3 CKD.

Authors:  Colin D Chue; Jonathan N Townend; William E Moody; Daniel Zehnder; Nadezhda A Wall; Lorraine Harper; Nicola C Edwards; Richard P Steeds; Charles J Ferro
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

10.  Associations between serum calcium, phosphorus and mortality among patients with coronary heart disease.

Authors:  Qian Chen; Yuan Zhang; Ding Ding; Dan Li; Yunou Yang; Qing Li; Xuechen Chen; Gang Hu; Wenhua Ling
Journal:  Eur J Nutr       Date:  2017-08-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.